Biopharm Co. Gets Rare Jump On $17.4M Ch. 11 Asset Sales
Biopharmaceutical company Achaogen Inc. received a rare running start in Delaware bankruptcy court Monday on an only partially cleared but vital series of Chapter 11 sale orders expected to net $17.4...To view the full article, register now.
Already a subscriber? Click here to view full article